As we age, our brain shrinks, losing nearly 5% of its volume per decade after age 40. This degeneration of the brain is a change that current longevity approaches have been unable to address. Dr. Sam Clark, Founder and CEO of Terran Biosciences, will present new research on a psychedelic-based therapeutic for neuroregeneration being developed for at-home use. This will be the first presentation of a clinical imaging study in humans showing that the effects of a psychedelic on neuronal connectivity occur in the absence of a perceptual trip.